发明名称 |
Liposome-entrapped topoisomerase inhibitors |
摘要 |
A composition for administration of a therapeutically effective dose of a topoisomerase inhibitor I or topoisomerase I/II inhibitor is described. The composition includes liposomes having an outer surface and an inner surface defining an aqueous liposome compartment, and being composed of a vesicle-forming lipid and of a vesicle-forming lipid derivatized with a hydrophilic polymer to form a coating of hydrophilic polymer chains on both the inner and outer surfaces of the liposomes. Entrapped in the liposomes is the topoisomerase inhibitor at a concentration of at least about 0.10 mumole drug per mumole lipid.
|
申请公布号 |
US2003133973(A1) |
申请公布日期 |
2003.07.17 |
申请号 |
US20020230796 |
申请日期 |
2002.08.29 |
申请人 |
SLATER JAMES L.;COLBERN GAIL T.;WORKING PETER K. |
发明人 |
SLATER JAMES L.;COLBERN GAIL T.;WORKING PETER K. |
分类号 |
A61K9/127;A61K31/00;A61K31/352;A61K31/435;A61K31/4375;A61K31/473;A61K31/4745;A61K31/496;A61K45/00;A61K47/28;A61K47/34;A61K47/36;A61K47/44;A61P35/00;A61P43/00;(IPC1-7):A61K31/496;A61K31/474 |
主分类号 |
A61K9/127 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|